Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Authors
Keywords
-
Journal
AIDS Research and Therapy
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-05
DOI
10.1186/s12981-022-00459-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination
- (2021) Virginia A Triant et al. CLINICAL INFECTIOUS DISEASES
- Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China
- (2020) Feng Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients
- (2020) Xiaoli Wang et al. CLINICAL INFECTIOUS DISEASES
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus
- (2020) Hsi-en Ho et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Immune response to hepatitis A vaccine in patients with HIV
- (2019) Carlos Fritzsche et al. VACCINE
- Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count
- (2019) Joon Young Song et al. Human Vaccines & Immunotherapeutics
- Impact of aging and HIV infection on serologic response to seasonal influenza vaccination
- (2018) Suresh Pallikkuth et al. AIDS
- B-cell responses to HIV infection
- (2017) Susan Moir et al. IMMUNOLOGICAL REVIEWS
- T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection
- (2017) Suresh Pallikkuth et al. Frontiers in Immunology
- HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine
- (2015) Varghese K. George et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
- (2009) Michael L. Landrum et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More